Home LiteratureArticle Details
PMID: 1349424 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis.

The New England journal of medicine ·Vol. 326 ·No. 22 ·1992-05-28 ·Pages 1464-8

Rothstein JD, Martin LJ, Kuncl RW

Abstract

Amyotrophic lateral sclerosis (ALS) is a chronic degenerative neurologic disorder characterized by the death of motor neurons in the cerebral cortex and spinal cord. Recent studies have suggested that the metabolism of glutamate, a potentially neurotoxic amino acid, is abnormal in patients with ALS. We hypothesized that the high-affinity glutamate transporter is the site of the defect. We measured high-affinity, sodium-dependent glutamate transport in synaptosomes from neural tissue obtained from 13 patients with ALS, 17 patients with no neurologic disease, and 27 patients with other neuro-degenerative diseases (Alzheimer's disease in 15 patients and Huntington's disease in 12 patients). The groups were comparable with respect to age and the interval between death and autopsy. Synaptosomes were prepared from spinal cord, motor cortex, sensory cortex, visual cortex, striatum, and hippocampus. We also measured sodium-dependent transport of gamma-aminobutyric acid and phenylalanine in the synaptosomal preparations. In patients with ALS, there was a marked decrease in the maximal velocity of transport for high-affinity glutamate uptake in synaptosomes from spinal cord (-59 percent, P less than 0.001), motor cortex (-70 percent, P less than 0.001), and somatosensory cortex (-39 percent, P less than 0.05), but not in those from visual cortex, striatum, or hippocampus. The affinity of the transporter for glutamate was not altered. No abnormalities in glutamate transport were found in synaptosomes from patients with other chronic neurodegenerative disorders. The transport of gamma-aminobutyric acid and phenylalanine was normal in patients with ALS. ALS is associated with a defect in high-affinity glutamate transport that has disease, region, and chemical specificity. Defects in the clearance of extracellular glutamate because of a faulty transporter could lead to neurotoxic levels of extracellular glutamate and thus be pathogenic in ALS.

MeSH Terms
Aged Alzheimer Disease/metabolism Amyotrophic Lateral Sclerosis/metabolism Biological Transport Brain/metabolism Female Glutamates/metabolism Glutamic Acid Humans Huntington Disease/metabolism In Vitro Techniques Male Middle Aged Motor Cortex/metabolism Phenylalanine/metabolism Somatosensory Cortex/metabolism Spinal Cord/metabolism Synaptosomes/chemistry Visual Cortex/metabolism gamma-Aminobutyric Acid/metabolism
Chemicals
Glutamates Glutamic Acid Phenylalanine gamma-Aminobutyric Acid
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Rothstein J D
Department of Neurology, Johns Hopkins University, Baltimore, MD 21205.
Martin L J
Kuncl R W
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
0028-4793
Published
1992-05-28
Pages
1464-8
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Grants
NINDS NIH HHS · NS01355 · United States
NINDS NIH HHS · NS30086 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]